Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity
Innate Immunity · 2021-04 · 27 (3) · 240-250
DOI: 10.1177/1753425921995577 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Innate Immunity, online erschienen am 01.03.2021. Verfasst von Reham Hammad und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pathology Department, Faculty of Medicine (for Girls), Al-Azhar University, Egypt. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Cell destruction results in plasma accumulation of cell-free DNA (cfDNA). Dynamic changes in circulating lymphocytes are features of COVID-19. We aimed to investigate if cfDNA level can serve in stratification of COVID-19 patients, and if cfDNA level is associated with alterations in lymphocyte subsets and neutrophil-to-lymphocyte ratio (NLR). This cross-sectional comparative study enrolled 64 SARS-CoV-2-positive patients. Patients were subdivided to severe and non-severe groups. Plasma cfDNA concentration was determined by real-time quantitative PCR. Lymphocyte subsets were assessed by flow cytometry. There was significant increase in cfDNA among severe cases when compared with non-severe cases. cfDNA showed positive correlation with NLR and inverse correlation with T cell percentage. cfDNA positively correlated with ferritin and C-reactive protein. The output data of performed ROC curves to differentiate severe from non-severe cases revealed that cfDNA at cut-off ≥17.31 ng/µl and AUC of 0.96 yielded (93%) sensitivity and (73%) specificity. In summary, excessive release of cfDNA can serve as sensitive COVID-19 severity predictor. There is an association between cfDNA up-regulation and NLR up-regulation and T cell percentage down-regulation. cfDNA level can be used in stratification and personalized monitoring strategies in COVID-19 patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pathology Department, Faculty of Medicine (for Girls), Al-Azhar University, Egypt.
- Internal Medicine Allergy and Clinical Immunology, Ain-Shams University, Egypt.
- Clinical Pathology Department, Faculty of Medicine (for Boys), Al-Azhar University, Egypt.
- Microbiology and Immunology Department, Faculty of Medicine (for Girls), Al-Azhar University, Egypt.
- Department of Internal Medicine, Al-Azhar University, Egypt.
- Clinical Pathology department Ain-Shams University, Egypt.
ORCID-Profile: Reham Hammad, Shaimaa Hani Fouad, Mohamed Alboraie
Zitieren
APA
Hammad, R., Eldosoky, M. A. E. R., Fouad, S. H., Elgendy, A., Tawfeik, A. M., Alboraie, M., & Abdelmaksoud, M. F. (2021). Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity. Innate Immunity, 27(3), 240-250. https://doi.org/10.1177/1753425921995577
Vancouver
Hammad R, Eldosoky MAER, Fouad SH, Elgendy A, Tawfeik AM, Alboraie M, et al. Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity. Innate Immunity. 2021;27(3):240-250. doi:10.1177/1753425921995577
BibTeX
@article{Hammad2021,
author = {Hammad, Reham and Eldosoky, Mona Abd El Rahman and Fouad, Shaimaa Hani and Elgendy, Abdelaleem and Tawfeik, Amany M and Alboraie, Mohamed and Abdelmaksoud, Mariam Fathy},
title = {Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity},
journal = {Innate Immunity},
year = {2021},
volume = {27},
number = {3},
pages = {240--250},
doi = {10.1177/1753425921995577}
}
EUVIMED